Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Cook
P C Dowling

Neurology

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Neurology|July 1, 1980
Multiple sclerosis and viruses: an overviewS D Cook, P C Dowling
Neurology|July 1, 1980
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitisP C Dowling, V V Bosch, S D Cook
Neurology|August 1, 1995
Canine distemper virus-specific antibodies in multiple sclerosisC Rohowsky-Kochan, P C Dowling, S D Cook
Neurology|April 1, 1985
Declining incidence of multiple sclerosis in the Orkney IslandsS D Cook, J I Cromarty, W Tapp, et al.
Neurology|July 1, 1988
Effect of total lymphoid irradiation on functional status in chronic multiple sclerosis: importance of lymphopenia early after treatment--the prosC Devereux, R Troiano, G Zito, et al.
Neurology|September 26, 2001
Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patientsS D Cook, J R Quinless, A Jotkowitz, et al.
Neurology|July 1, 1992
Rate and types of fractures in corticosteroid-treated multiple sclerosis patientsR A Troiano, A Jotkowitz, S D Cook, et al.
Neurology|April 1, 1991
Increased free light chains in the urine from patients with multiple sclerosisP D Mehta, S D Cook, R A Troiano, et al.
Neurology|August 1, 1991
Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndromeS Bansil, F A Mithen, S D Cook, et al.
Neurology|April 24, 2002
Quantitative functional measures in MS: what is a reliable change?S R Schwid, A D Goodman, M P McDermott, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neurology|July 1, 1980
Multiple sclerosis and viruses: an overviewS D Cook, P C Dowling
Neurology|July 1, 1980
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitisP C Dowling, V V Bosch, S D Cook
Neurology|August 1, 1995
Canine distemper virus-specific antibodies in multiple sclerosisC Rohowsky-Kochan, P C Dowling, S D Cook
Neurology|April 1, 1985
Declining incidence of multiple sclerosis in the Orkney IslandsS D Cook, J I Cromarty, W Tapp, et al.
Neurology|July 1, 1988
Effect of total lymphoid irradiation on functional status in chronic multiple sclerosis: importance of lymphopenia early after treatment--the prosC Devereux, R Troiano, G Zito, et al.
Neurology|September 26, 2001
Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patientsS D Cook, J R Quinless, A Jotkowitz, et al.
Neurology|July 1, 1992
Rate and types of fractures in corticosteroid-treated multiple sclerosis patientsR A Troiano, A Jotkowitz, S D Cook, et al.
Neurology|April 1, 1991
Increased free light chains in the urine from patients with multiple sclerosisP D Mehta, S D Cook, R A Troiano, et al.
Neurology|August 1, 1991
Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndromeS Bansil, F A Mithen, S D Cook, et al.
Neurology|April 24, 2002
Quantitative functional measures in MS: what is a reliable change?S R Schwid, A D Goodman, M P McDermott, et al.
Pageof 2